aid: adcendo
name: Adcendo
description: 'Adcendo ApS is a clinical-stage biopharmaceutical company headquartered
  in Copenhagen, Denmark, with US operations in Boston, Massachusetts, developing a
  new generation of antibody-drug conjugates (ADCs) for cancers with high unmet medical
  need. Founded in 2017 out of research by Lars Henning Engelholm and Niels Behrendt,
  the company advances a clinical and pre-clinical pipeline that includes ADCE-T02
  (targeting Tissue Factor, in the Phase 1b Tiffany-01 study across advanced solid
  tumors), ADCE-D01 (targeting uPARAP, granted FDA Fast Track designation for soft
  tissue sarcoma), and the pre-clinical ADCE-B05. Adcendo is a privately held,
  venture-backed therapeutics developer; it publishes a corporate website, pipeline
  and publications pages, and investor press releases, but it operates no developer
  program, public API, or machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/adcendo/refs/heads/main/apis.yml
image: https://adcendo.com/wp-content/uploads/adcendo-logo.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Life Sciences
- Antibody-Drug Conjugates
- Clinical Stage
- Denmark
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/adcendo-domain-security.yml
- type: Website
  url: https://adcendo.com/
- type: About
  url: https://adcendo.com/adcendo/about/about-adcendo/
- type: Pipeline
  url: https://adcendo.com/adcendo/our-science/pipeline/
- type: Publications
  url: https://adcendo.com/adcendo/our-science/key-publications/
- type: PressReleases
  url: https://adcendo.com/adcendo/investors/press-releases/
- type: BlogRSS
  url: https://adcendo.com/feed/
- type: Careers
  url: https://adcendo.com/adcendo/your-careers-and-our-values/
- type: Contact
  url: https://adcendo.com/contact/
- type: PrivacyPolicy
  url: https://adcendo.com/privacy-policy/
- type: CookiePolicy
  url: https://adcendo.com/cookie-policy/
- type: LLMsTxt
  url: llms/adcendo-llms.txt
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Adcendo is a clinical-stage biopharmaceutical company developing antibody-drug
    conjugates; its only machine-readable endpoint is the stock WordPress REST API
    of its marketing CMS at /wp-json/ (LiteSpeed, Wordfence, Divi and Google Site Kit
    plugin routes), and every OpenAPI, GraphQL, MCP and A2A discovery path on adcendo.com
    returns 404.
  evidence:
  - url: https://adcendo.com/openapi.json
    status: 404
  - url: https://adcendo.com/graphql
    status: 404
  - url: https://adcendo.com/.well-known/agent-card.json
    status: 404
  - url: https://adcendo.com/.well-known/security.txt
    status: 404
  - url: https://adcendo.com/wp-json/
    status: 200
  checked: '2026-08-06'